Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 27, 2018

Primary Completion Date

March 6, 2024

Study Completion Date

March 6, 2024

Conditions
Multiple Myeloma
Interventions
DIAGNOSTIC_TEST

Structural Image

Patients will undergo structural and functional (rsfMRI) brain MRIs (total time= \~15 minutes) at enrollment (prior to HD-Chemo/ASCT) and approximately 3-4 months after ASCT.

DIAGNOSTIC_TEST

Functional Image

Patients will undergo structural and functional (rsfMRI) brain MRIs (total time= \~15 minutes) at enrollment (prior to HD-Chemo/ASCT) and approximately 3-4 months after ASCT.

BEHAVIORAL

Digit Span subtest

Evaluates auditory attention and working memory

BEHAVIORAL

Brief Test of Attention

Assesses selective auditory attention

BEHAVIORAL

Trail Making Test (Parts A & B)

Assesses visual scanning, graphomotor speed, and setshifting

BEHAVIORAL

Auditory Consonant Trigrams Test

Assesses attention and susceptibility to interference

BEHAVIORAL

Controlled Oral Word Association Test

A timed test of verbal fluency.

BEHAVIORAL

Hopkins Verbal Learning Test-Revised

The HVLT-R is a test of verbal learning and recall.

BEHAVIORAL

The Center for Epidemiological Study-Depression

assesses perceived depression

BEHAVIORAL

The Functional Assessment of Chronic Illness Therapy-Fatigue Subscale, Version 4

A 13-item questionnaire designed to assess symptoms and concerns specific to the QOL of patients with fatigue

OTHER

Blood draw

Blood samples will be collected at each time point (pre-ASCT; 3-4 months and post-ASCT) to assess serum levels of inflammatory cytokines.

Trial Locations (2)

10065

Memorial Sloan Kettering Cancer Center, New York

08903

Rutgers University - Data Analysis, New Brunswick

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03508765 - Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation | Biotech Hunter | Biotech Hunter